Case Studies
Selection of Breakthrough Technology & Suitable Partner – Gene Editing Platforms
Life Sciences
A leading US pharmaceutical company was interested to understand the best in the class technology landscape in the Gene editing platforms for portfolio expansion. FutureBridge consulting team worked along with the portfolio function and developed a robust toolkit to prioritize technologies beyond CRISPR/CaS9 and benchmarked potential partners for future licensing and partnerships.
210827-Hero-Case-Study-_2-Gene-Editing-Technologies_-Revised
